Primary study · included by 1 review

Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study

Klein Hesselink 2016 · Klein Hesselink Esther N., Brouwers Adrienne H., de Jong Johan R., et al. · Journal of Nuclear Medicine · 2016

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Klein Hesselink 2016 · Reference list; Fig. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.60 [0.28, 0.85]3 studies · 1502 participantsGRADE not reported

1 including review in total.